Literature DB >> 6644890

The stone clinic effect in patients with idiopathic calcium urolithiasis.

D H Hosking, S B Erickson, C J Van den Berg, D M Wilson, L H Smith.   

Abstract

The "stone clinic effect" refers to the effect of encouraging a high intake of fluid and avoiding dietary excesses on stone formation and growth in patients with urolithiasis. To determine the extent of this effect we reviewed the clinical courses of 108 patients with idiopathic calcium urolithiasis and indeterminant metabolic activity. There was no evidence of stone growth or new stone formation (metabolic inactivity) after a mean followup of 62.6 months in 63 of the 108 patients (58.3 per cent), including 12 of 17 (70.6 per cent) with hypercalciuria and 7 of 15 (46.7 per cent) with hyperuricosuria. Comparison of initial and followup 24-hour urine volumes demonstrated a significant increase in patients who were metabolically inactive at followup (p less than 0.0005), while no increase was detected in patients who were metabolically active at followup. We recommend that specific drug therapy should not be given to patients with idiopathic calcium urolithiasis until the stone clinic effect has been evaluated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644890     DOI: 10.1016/s0022-5347(17)51711-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  38 in total

Review 1.  Nephrology: 1. Investigation and treatment of recurrent kidney stones.

Authors:  A Ross Morton; Eduard A Iliescu; James W L Wilson
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

Review 2.  Prospective therapeutic studies in nephrolithiasis.

Authors:  D K Ackermann
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 3.  Diet and calcium stones.

Authors:  J Hughes; R W Norman
Journal:  CMAJ       Date:  1992-01-15       Impact factor: 8.262

Review 4.  [Prevention of nephrolithiasis. Established strategies and new concepts].

Authors:  M Straub; R E Hautmann
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

5.  Metabolic testing of the first-time calcium oxalate stone former: Is it indicated? No.

Authors:  Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-06       Impact factor: 1.862

6.  Arguments for a comprehensive metabolic evaluation of the first-time stone former.

Authors:  Ryan F Paterson
Journal:  Can Urol Assoc J       Date:  2010-06       Impact factor: 1.862

7.  Evaluation and medical management of the kidney stone patient.

Authors:  Ryan Paterson; Alfonso Fernandez; Hassan Razvi; Roger Sutton
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

8.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

9.  Development of metaphylaxis in calcium urolithiasis: a restriction of conventional drug therapy.

Authors:  R Kocvara; G Louzenský; J Tuíková
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

10.  Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França; Marcelo Ferraz Oliveira Souto
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.